Improved Process for Paroxetine Hydrochloride Substantially Free from Potential Impurities

REFERENCES

• Katzman , M. A. Current considerations in the treatment of generalized anxiety disorder . CNS Drugs 2009 , 23 ( 2 ), 103 – 120 .
   Web of Science ®Google Scholar
• Barbui , C. ; Furukawa , T. A. ; Cipriani , A. Effectiveness of selective serotonin reuptake inhibitors . Can. Med. Assoc. J. 2008 , 178 ( 3 ), 296 – 305 .
   Web of Science ®Google Scholar
• Yonkers , K. A. ; Gullion , C. ; Williams , A. ; Novak , K. ; Rush , A. J. Paroxetine as a treatment for premenstrual dysphoric disorder . J. Clin. Psychopharm. 1996 , 16 , 3 – 8 .
   PubMed Web of Science ®Google Scholar
• Christensen , J. A. ; Squires , R. F. 4-Phenylpiperidine compounds. U.S. Patent 4, 007, 196 , 1977 .
   Google Scholar
• Barnes , R. D. ; Wood-Kaczmar , M. W. ; Curzons , A. D. ; Lynch , I. R. ; Richardson , J. E. ; Buxton , P. C. Anti-depressant crystalline paroxetine hydrochloride hemihydrates. U.S. Patent 4, 721, 723 , 1988 .
   Google Scholar
• (a) Lemmens , J. M. ; Peters , T. H. A. ; Picha , F. Process for the production of paroxetine U.S. Patent 6, 686, 473 B2 , 2004 ; (b) Al-Deeb Al-Ghazawi , A. K. ; Craig , A. S. ; Elder , D. P. ; Jacewiez , V. W. ; Jones , D. A. ; O' Keefe , D. ; Patel , P. M. ; Urquhart , M. ; Ward , N. U.S. Patent 0023252 A1 , 2001 .
   Google Scholar
• Borrett , G. T. ; Crowe , D. ; Ward , N. ; Wells , A. S. Process for the preparation of paroxetine. WO Patent 0129031 A1 , 2001 .
   Google Scholar
• Thippannachar , V. M. ; Jayantilal , P. V. ; Elati , C. R. R. ; Kolla , N. K. ; Chlamala , S. R. Preparation of paroxetine hydrochloride hemihydrates. U.S. Patent 0264637A1 , 2006 .
   Google Scholar
• International Conference on Harmonization (ICH) Guidelines. Q8, Pharmaceutical Development, 2005; Q9, Quality Risk Management, 2006 .
   Google Scholar
• Nasr , M. In Pharmaceutical Quality Assessment System (PQAS) in the 21st Century , CDER, FDA : Philadelphia , 2006 .
   Google Scholar
• James , A. I. Paroxetine hydrochloride hemihydrates. Acta Cryst. 1999, C55, 432–434.
   Google Scholar
• (a) Hanselmann , R. ; Johnson , G. ; Maxwell , M. R. ; Huang , S.-T. Identification and suppression of a dimer impurity in the development of delafloxacin . Org. Process Res. Dev. 2009 , 13 , 54 – 59 ; (b) Huang , Y. ; Ye , Q. ; Guo , Z. ; Venkatapuram , A. P. ; Grosso , J. A. Identification of critical process impurities and their impact on process research and development . Org. Process Res. Dev. 2008 , 12 , 632 – 636 ; (c) Wirth , D. D. ; Miller , M. S. ; Boini , S. K. ; Koenig , T. M. Purification of dirithromycin: Impurity reduction and polymorph manipulation . Org. Process Res. Dev. 2000 , 4 , 513 – 519 .
   Web of Science ®Google Scholar
• (a) The United States Pharmacopeia, (USP 31-NF 26). Vol. 2, 3. United States Pharmacopeia Convention: Rockville, MD, pp. 33(5), p. 932; (b) The European Pharmacopeia 5, p. 2195; (c) http://www.usp.org .
   Google Scholar
• (a) http://www.molcan.com/paroxetine.htm; (b) Impurities 17 and 18 were not synthesized .
   Google Scholar
• Zukowski , J. ; Brightwell , M. ; de Biasi , V. Chiral HPLC method for chiral purity determination of paroxetine drug substance . Chirality 2003 , 15 , 600 – 604 .
   PubMed Web of Science ®Google Scholar
• Wimalasena , D. S. ; Perera , R. P. ; Heyen , B. J. ; Balasooriya , I. S. ; Wimalasena , K. Vesicular monoamine transporter substrate/inhibitor activity of MPTP/MPP derivatives: A structure–activity study . J. Med. Chem. 2008 , 51 , 760 – 768 .
   PubMed Web of Science ®Google Scholar
• Wei , P. ; Kaatz , G. W. ; Kerns , R. J. Structural differences between paroxetine and femoxetine responsible for differential inhibition of Staphylococcus aureus efflux pumps . Bioorg. Med. Chem. Lett. 2004 , 14 , 3093 – 3097 .
   PubMed Web of Science ®Google Scholar
• German , N. ; Kaatz , G. W. ; Kerns , R. J. Synthesis and evaluation of PSSRI-based inhibitors of Staphylococcus aureus multidrug efflux pumps . Bioorg. Med. Chem. Lett. 2008 , 18 , 1368 – 1373 .
   PubMed Web of Science ®Google Scholar
• Communication No. IPDO-IPM-00218.
   Google Scholar